Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:1058-1062

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurumatani, T.
Right arrow Articles by Kontos, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurumatani, T.
Right arrow Articles by Kontos, H. A.

(Stroke. 1998;29:1058-1062.)
© 1998 American Heart Association, Inc.


Original Contributions

White Matter Changes in the Gerbil Brain Under Chronic Cerebral Hypoperfusion

Takahiro Kurumatani, MD, PhD; Takashi Kudo, MD, PhD; Yasumitsu Ikura, MD, PhD; Masatoshi Takeda, MD, PhD

From the Department of Neuropsychiatry, Osaka University Medical School (Japan).

Correspondence to Takashi Kudo, MD, PhD, Department of Neuropsychiatry, Osaka University Medical School, 2–2 Yamadaoda, Suita, Osaka 565, Japan. E-mail kudo{at}psy.med.osaka-u.ac.jp

Background and Purpose—An animal model of chronic cerebral hypoperfusion was developed with coiled clips applied to both carotid arteries of adult Mongolian gerbils for between 1 week and 2 months. In the brain of this animal model, rarefaction of white matter with dilatation of the ventricles was frequently observed. To better understand the mechanism of white matter alteration under cerebral hypoperfusion, the chronological sequence of molecular changes in the cerebral white matter of the animal model was determined.

Methods—Specially designed coiled clips were placed around both carotid arteries of Mongolian gerbils to create stenosis without occlusion. Changes in levels of myelin basic protein (MBP) as a marker of myelin, neurofilament H (NFH) as a marker of axonal proteins, and glial fibrillary acidic protein (GFAP) in astroglia after 2 months of cerebral hypoperfusion were analyzed with Western blotting and enzyme-linked immunosorbent assay.

Results—Western blotting of the white matter after 2 months of hypoperfusion showed that the levels of MBP and NFH decreased, whereas that of GFAP increased. The time course of MBP and NFH changes determined with enzyme-linked immunosorbent assay revealed that the change of MBP preceded that of NFH.

Conclusions—In the present study it was shown that the damage to myelin precedes that to the axon in the white matter in a chronic cerebral hypoperfusion animal model, suggesting that the change in myelin is the primary pathological event in the cerebral white matter under chronic hypoperfusion. The present study may help in understanding the mechanisms of white matter pathology in leukoaraiosis.

Editorial Comment

Hermes A. Kontos, MD, PhD

Associate Editor for Basic Science, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia




This article has been cited by other articles:


Home page
StrokeHome page
M. Shibata, N. Yamasaki, T. Miyakawa, R. N. Kalaria, Y. Fujita, R. Ohtani, M. Ihara, R. Takahashi, and H. Tomimoto
Selective Impairment of Working Memory in a Mouse Model of Chronic Cerebral Hypoperfusion
Stroke, October 1, 2007; 38(10): 2826 - 2832.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. M. Moody, C. R. Thore, J. A. Anstrom, V. R. Challa, C. D. Langefeld, and W. R. Brown
Quantification of Afferent Vessels Shows Reduced Brain Vascular Density in Subjects with Leukoaraiosis
Radiology, December 1, 2004; 233(3): 883 - 890.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Shimamura, N. Sato, K. Oshima, M. Aoki, H. Kurinami, S. Waguri, Y. Uchiyama, T. Ogihara, Y. Kaneda, and R. Morishita
Novel Therapeutic Strategy to Treat Brain Ischemia: Overexpression of Hepatocyte Growth Factor Gene Reduced Ischemic Injury Without Cerebral Edema in Rat Model
Circulation, January 27, 2004; 109(3): 424 - 431.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L. Soinne, J. Helenius, E. Saimanen, O. Salonen, P. J. Lindsberg, M. Kaste, and T. Tatlisumak
Brain diffusion changes in carotid occlusive disease treated with endarterectomy
Neurology, October 28, 2003; 61(8): 1061 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
G. Bartzokis, J. L. Cummings, D. Sultzer, V. W. Henderson, K. H. Nuechterlein, and J. Mintz
White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease: A Magnetic Resonance Imaging Study
Arch Neurol, March 1, 2003; 60(3): 393 - 398.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S.-i. Yoshimura, R. Morishita, K. Hayashi, J. Kokuzawa, M. Aoki, K. Matsumoto, T. Nakamura, T. Ogihara, N. Sakai, and Y. Kaneda
Gene Transfer of Hepatocyte Growth Factor to Subarachnoid Space in Cerebral Hypoperfusion Model
Hypertension, May 1, 2002; 39(5): 1028 - 1034.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
N. Molko, S. Pappata, J.F. Mangin, C. Poupon, K. Vahedi, A. Jobert, D. LeBihan, M.G. Bousser, and H. Chabriat
Diffusion Tensor Imaging Study of Subcortical Gray Matter in CADASIL
Stroke, September 1, 2001; 32(9): 2049 - 2054.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
H. Kado, H. Kimura, T. Tsuchida, Y. Yonekura, T. Tokime, Y. Tokuriki, and H. Itoh
Abnormal Magnetization Transfer Ratios in Normal-appearing White Matter on Conventional MR Images of Patients with Occlusive Cerebrovascular Disease
AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 922 - 927.
[Abstract] [Full Text]


Home page
StrokeHome page
G. K. Kanellopoulos, X. M. Xu, C. Y. Hsu, X. Lu, T. M. Sundt, N. T. Kouchoukos, and P. H. Chan
White Matter Injury in Spinal Cord Ischemia : Protection by AMPA/Kainate Glutamate Receptor Antagonism Editorial Comment: Protection by AMPA/Kainate Glutamate Receptor Antagonism
Stroke, August 1, 2000; 31(8): 1945 - 1952.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. Chabriat, S. Pappata, C. Poupon, C. A. Clark, K. Vahedi, F. Poupon, J. F. Mangin, M. Pachot-Clouard, A. Jobert, D. Le Bihan, et al.
Clinical Severity in CADASIL Related to Ultrastructural Damage in White Matter : In Vivo Study With Diffusion Tensor MRI
Stroke, December 1, 1999; 30(12): 2637 - 2643.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. DeCarli, T. Reed, B. L. Miller, P. A. Wolf, G. E. Swan, and D. Carmelli
Impact of Apolipoprotein E {epsilon}4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin Study
Stroke, August 1, 1999; 30(8): 1548 - 1553.
[Abstract] [Full Text] [PDF]